Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Charles River Labs Intl buy Citigroup Inc.

Charles River Labs Intl
Start price
€135.75
09.07.25 / 50%
Target price
€170.62
09.07.26
Performance (%)
26.78%
Price
€172.10
23.12.25
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 26.78%. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Charles River Labs Intl 2.046% 2.046%
iShares Core DAX® 0.765% 4.791%
iShares Nasdaq 100 1.418% 3.133%
iShares Nikkei 225® 0.658% 0.972%
iShares S&P 500 1.310% 2.279%

Comments by Citigroup_Inc_ for this prediction

In the thread Charles River Labs Intl diskutieren
Prediction Buy
Perf. (%) 26.78%
Target price 170.620
Change
Ends at 09.07.26

Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $200.00 price target on the stock, up previously from $150.00.
Ratings data for CRL provided by MarketBeat

Citigroup Inc. 
0
Report Share
09.07.25

Stopped prediction by Citigroup_Inc_ for Charles River Labs Intl

sell
Charles River Labs Intl

Start price
Target price
Perf. (%)
€175.45
01.10.24
€158.03
01.10.25
-17.50%
02.10.25

Citigroup Inc. 
01.10.24 50%